# The Campbell's Company (CPB) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Consumer Defensive / Food & Staples Retailing. Price $21.38, market value $6.4 billion.

## Valuation
- **P/E (trailing): 16.3×** (5-yr avg 15.9×, 3-yr avg 17.2×). The Campbell's Company trades at 16.3× trailing earnings, close to its own five-year average of 15.9×. The Consumer Defensive median in the September 2026 study was 20.1×. Forward P/E is 11.7×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 1.84**. A PEG of 1.84 is in the range usually read as fairly priced for its growth.
- **Price / sales: 0.6×**. Each dollar of revenue is priced at 0.6×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.6×**. The shares trade at 1.6× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 4.6×**. Enterprise value is 4.6× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 10.5%** (5-yr avg 6.7%). Free cash flow equals 10.5% of the market value, above its five-year average of 6.7%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 6.1%**. The inverse of the P/E: 6.1% of the price is earned each year.

## Profitability
- **Operating margin: 11.3%**. 11.3% of revenue is left after running the business.
- **Net margin: 5.9%**. 5.9% of each dollar of sales reaches the bottom line.
- **Return on equity: 15.4%**. 15.4% on shareholders' equity is solid.
- **Return on invested capital: 19.5%**. Return on all capital, debt included, is 19.5%: comfortably above what that capital costs.
- **Return on assets: 4.1%**. Each dollar of assets produces 4.1% of profit.

## Growth
- **Revenue growth (1 yr): 6.4%** (3-yr 6.2%/yr, 5-yr 3.4%/yr). Revenue grew 6.4% over the last year, against 3.4% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 6.3%** (3-yr -7.1%/yr, 5-yr -17.8%/yr). Earnings per share rose 6.3%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): -9.1%/yr**. Free cash flow has compounded at -9.1% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.20**. Debt is 0.20 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.4×**. It would take 0.4 years of operating earnings to repay net borrowings, within the comfortable range.
- **Altman Z-score: 1.65**. A Z-score of 1.65 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 4.68%** ($1.56 per share, trailing). The Campbell's Company yields 4.68%, an income-level yield.
- **Payout ratio: 76%** (70% of free cash flow). 76% of earnings goes out as dividends, leaving a thin cushion.
- **Consecutive years of increases: 12**. 12 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 2.2%/yr** (1-yr 5.4%). The dividend has grown 2.2% a year over five years.

## Analyst view
- **Analyst consensus: hold** (17 analysts). 17 analysts cover The Campbell's Company; the consensus is hold, with an average price target of $22.00 (+3% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -30.4%** (YTD -19.4%, 3-mo 0.3%). The shares are down 30.4% over twelve months including dividends.
- **From 52-week high: -37.4%** (9.3% above the low). Trading 37% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 36**. An RSI of 36 is neutral.
- **Beta (1 yr): -0.26** (volatility 32%). Beta of -0.26 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CPB · Page: https://foliofundamentals.com/stocks/cpb

Not investment advice.